Streetbeat News

Regulatory

RCM

R1 RCM Inc. (NASDAQ:RCM) has completed the restatement of its previously issued financial statements for 2022, 2021, and the first two quarters of 2023. The restatement had no material impact on revenue or Adjusted EBITDA for 2022 and 2021, no impact on the first three quarters of 2023 results, and no effect on R1's cash, business operations, or 2023 outlook.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:18 pm

ITRM

Iterum Therapeutics has regained compliance with the Nasdaq minimum bid price requirement, ensuring its continued listing on the exchange. The company's stock had previously been at risk of delisting due to a bid price that fell below the $1.00 minimum threshold. By meeting this requirement, Iterum Therapeutics avoids potential delisting and the associated negative consequences for its stock's liquidity and investor perception.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:13 pm

VINE

Fresh Vine Wine Inc. (VINE) has announced a non-binding letter of intent to merge with Notes Live, Inc., a live entertainment and hospitality company. The definitive agreement is expected by January 31, 2024, with a potential closing in Q2 2024. Notes Live owners may acquire over 90% of Fresh Vine post-transaction. Conditions include due diligence, financing, regulatory approvals, and NYSE American listing maintenance. Fresh Vine has also made a $500,000 equity investment in Notes Live, which may be refundable. The transaction aims to provide customers an opportunity to invest in Notes Live's vision for live music experiences.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:09 pm

VCNX

Nasdaq has granted Vaccinex, Inc. an extension until March 4, 2024, to regain compliance with the Nasdaq Listing Rule. This extension provides Vaccinex with additional time to meet the minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:09 pm

NRGV

Energy Vault Holdings, Inc. (NYSE:NRGV) received a positive technical due diligence evaluation from DNV for its B-VAULT battery energy storage system (BESS), confirming its performance, safety, and reliability. The report highlights B-VAULT's flexibility, integration capabilities, and compliance with industry standards. DNV's evaluation, which included a factory visit, supports the bankability of B-VAULT for lenders and customers involved in energy storage projects. Energy Vault's BESS solutions are designed to meet diverse customer needs and are currently contracted or under construction in the US, Europe, and Australia.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:08 pm

DAR

Darling Ingredients Inc. (NYSE:DAR) announced that its health brand Rousselot received a U.S. patent for StabiCaps, a gelatin technology enhancing soft gel capsules' stability and efficacy. StabiCaps prevents crosslinking issues, ensuring better release of active ingredients. The technology, which also holds a European patent, is part of Rousselot's portfolio aimed at the nutra- and pharmaceutical markets. The global soft gel capsules market is expected to grow at a 4.3% CAGR from 2023 to 2033.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:06 pm

FDMT

4D Molecular Therapeutics will present interim data from the Phase 2 PRISM trial at the Angiogenesis, Exudation, and Degeneration 2024 Conference. The data pertains to the 24-week randomized dose expansion stage of the trial.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:05 pm

SLNA

Selina Hospitality PLC (NASDAQ: SLNA) announced plans for fundraising and liability management, including a potential $68 million in strategic investments led by Osprey Investments Limited and others. The company aims to restructure its $147.5 million 6.00% convertible senior notes due 2026, with agreements in principle for a $28 million equity financing and an optional $40 million equity financing. The restructuring includes converting some debt to equity, extending maturity dates, and securing the Selina brand as collateral. The transactions are subject to definitive agreements and shareholder approval, with the goal of strengthening the balance sheet and achieving profitability.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:04 pm

MIRA

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) has announced promising results from AI simulations for MIRA1a, a potential treatment for anxiety, appetite, and cognition issues. The simulations, conducted with InSilicoTrials, suggest MIRA1a's advantages over THC, including fewer side effects. MIRA1a targets specific brain receptors and may offer superior anti-anxiety effects, appetite suppression, and cognitive enhancement. The company is working towards an IND Application with the FDA, positioning MIRA1a as a significant development in neuropharmacology.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:03 pm

LUNR

Intuitive Machines, Inc. has successfully delivered its IM-1 mission Nova-C lunar lander to Cape Canaveral, Florida. The launch, in coordination with SpaceX, is targeted for no earlier than January 12, 2024. The mission is part of NASA's CLPS initiative, aiming to establish a sustainable human presence on the Moon. The lander was completed in September and will be operated from Houston, Texas, with a journey of approximately six-and-a-half days to the Moon.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:03 pm